- Home
- LSF vs VNRX Comparison
LSF vs VNRX Comparison
Compare LSF & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LSF | VNRX |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.8M | 31.9M |
| IPO Year | 2020 | 2012 |
Fundamental Metrics
Financial Performance| Metric | LSF | VNRX |
|---|---|---|
| Price | $2.70 | $0.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $12.00 | $2.50 |
| AVG Volume (30 Days) | 64.0K | ★ 1.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.28 | 38.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,295,137.00 | $1,233,511.00 |
| Revenue This Year | $15.87 | $60.84 |
| Revenue Next Year | $14.98 | $404.89 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 26.50 | ★ 59.10 |
| 52 Week Low | $1.98 | $0.17 |
| 52 Week High | $7.94 | $0.94 |
Technical Indicators
Market Signals| Indicator | LSF | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 39.41 | 36.77 |
| Support Level | $2.46 | $0.17 |
| Resistance Level | $2.76 | $0.33 |
| Average True Range (ATR) | 0.21 | 0.02 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 12.90 | 24.46 |
Price Performance
Historical ComparisonAbout LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.